Gastrointestinal symptoms in COVID-19: the long and the short of it

被引:34
作者
Freedberg, Daniel E. [1 ,2 ]
Chang, Lin [3 ,4 ]
机构
[1] Columbia Univ, Irving Med Ctr, Div Digest & Liver Dis, New York, NY 10032 USA
[2] Columbia Univ, Irving Med Ctr, Columbia Mailman Sch Publ Hlth, New York, NY 10032 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA 90095 USA
关键词
COVID-19; enteric infections; gastrointestinal symptoms; gut microbiome; irritable bowel syndrome; postinfection irritable bowel syndrome; SARS-CoV-2; IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; INFECTION; PRUCALOPRIDE; SARS-COV-2; DEPRESSION; ALOSETRON; ENTERITIS; OUTCOMES;
D O I
10.1097/MOG.0000000000000876
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review A large and growing number of patients have persistent gastrointestinal symptoms that they attribute to COVID-19. SARS-CoV-2, the virus that causes COVID-19, replicates within the gut and acute COVID-19 is associated with alteration of the gut microbiome. This article reviews recent observational data related to gastrointestinal symptoms in 'long COVID' and discusses pathophysiologic mechanisms that might explain persistent post-COVID gastrointestinal symptoms. Recent findings Gastrointestinal symptoms are present in half of the patients with acute COVID-19, persist 6 months after COVID-19 in 10-25% of patients, and are rated as the most bothersome symptom in 11% of all patients. These symptoms include heartburn, constipation, diarrhoea and abdominal pain and decline in prevalence with the passage of time. Long COVID gastrointestinal symptoms are associated with mental health symptoms (anxiety and depression) that predate COVID-19 and also with mental health symptoms that are concurrent, after recovery from COVID-19. The cause of long COVID gastrointestinal symptoms is unknown and hypotheses include the SARS-CoV-2 virus itself, which infects the gastrointestinal tract; COVID-19, which can be accompanied by gut microbiome changes, a profound systemic inflammatory response and critical illness; and/or effects of pandemic stress on gastrointestinal function and symptom perception, which may be unrelated to either SARS-CoV-2 or to COVID-19. Summary New, persistent gastrointestinal symptoms are commonly reported after recovery from COVID-19. The pathophysiology of these symptoms is unknown but likely to be multifactorial.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 68 条
[1]  
Almario CV, 2021, AM J GASTROENTEROL, V116, pS220
[2]  
[Anonymous], ONLINE DATA US CTR D
[3]   Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome [J].
Barbara, Giovanni ;
Grover, Madhusudan ;
Bercik, Premysl ;
Corsetti, Maura ;
Ghoshal, Uday C. ;
Ohman, Lena ;
Rajilic-Stojanovic, Mirjana .
GASTROENTEROLOGY, 2019, 156 (01) :46-+
[4]   Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms [J].
Blackett, John W. ;
Wainberg, Milton ;
Elkind, Mitchell S. V. ;
Freedberg, Daniel E. .
GASTROENTEROLOGY, 2022, 162 (02) :648-+
[5]   Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19 [J].
Blackett, John W. ;
Li, Jianhua ;
Jodorkovsky, Daniela ;
Freedberg, Daniel E. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (03)
[6]   Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19 [J].
Britton, Graham J. ;
Chen-Liaw, Alice ;
Cossarini, Francesca ;
Livanos, Alexandra E. ;
Spindler, Matthew P. ;
Plitt, Tamar ;
Eggers, Joseph ;
Mogno, Ilaria ;
Gonzalez-Reiche, Ana S. ;
Siu, Sophia ;
Tankelevich, Michael ;
Grinspan, Lauren Tal ;
Dixon, Rebekah E. ;
Jha, Divya ;
van de Guchte, Adriana ;
Khan, Zenab ;
Martinez-Delgado, Gustavo ;
Amanat, Fatima ;
Hoagland, Daisy A. ;
TenOever, Benjamin R. ;
Dubinsky, Marla C. ;
Merad, Miriam ;
van Bakel, Harm ;
Krammer, Florian ;
Bongers, Gerold ;
Mehandru, Saurabh ;
Faith, Jeremiah J. .
SCIENTIFIC REPORTS, 2021, 11 (01) :13308
[7]   Mental health concerns during the COVID-19 pandemic as revealed by helpline calls [J].
Bruelhart, Marius ;
Klotzbuecher, Valentin ;
Lalive, Rafael ;
Reich, Stephanie K. .
NATURE, 2021, 600 (7887) :121-+
[8]   Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs [J].
Cai, Miao ;
Bowe, Benjamin ;
Xie, Yan ;
Al-Aly, Ziyad .
BMJ OPEN, 2021, 11 (08)
[9]   A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome [J].
Camilleri, M ;
Chey, WY ;
Mayer, EA ;
Northcutt, AR ;
Heath, A ;
Dukes, GE ;
McSorley, D ;
Mangel, AM .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1733-1740
[10]   Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome [J].
Carroll, I. M. ;
Ringel-Kulka, T. ;
Siddle, J. P. ;
Ringel, Y. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (06) :521-+